Hisamitsu Pharmaceutical HTSUF Stock
Hisamitsu Pharmaceutical Price Chart
Hisamitsu Pharmaceutical HTSUF Financial and Trading Overview
| Hisamitsu Pharmaceutical stock price | 29 USD |
| Previous Close | 29 USD |
| Open | 29 USD |
| Bid | 36.18 USD x 10000 |
| Ask | 41.12 USD x 10000 |
| Day's Range | 29 - 29 USD |
| 52 Week Range | 28.94 - 32.3 USD |
| Volume | 100 USD |
| Avg. Volume | 0 USD |
| Market Cap | 2.04B USD |
| Beta (5Y Monthly) | 0.291 |
| PE Ratio (TTM) | 16.763006 |
| EPS (TTM) | 1.73 USD |
| Forward Dividend & Yield | 0.61 (2.10%) |
| Ex-Dividend Date | February 26, 2026 |
| 1y Target Est | N/A |
HTSUF Valuation Measures
| Enterprise Value | -111347351552 USD |
| Trailing P/E | 16.763006 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.012523585 |
| Price/Book (mrq) | 1.0976264 |
| Enterprise Value/Revenue | -0.683 |
| Enterprise Value/EBITDA | -4.459 |
Trading Information
Hisamitsu Pharmaceutical Stock Price History
| Beta (5Y Monthly) | 0.291 |
| 52-Week Change | -10.21% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 32.3 USD |
| 52 Week Low | 28.94 USD |
| 50-Day Moving Average | 29 USD |
| 200-Day Moving Average | 29 USD |
HTSUF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 70.4M |
| Float | 22.78M |
| Short Ratio | N/A |
| % Held by Insiders | 84.39% |
| % Held by Institutions | 32.17% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 45 |
| Trailing Annual Dividend Yield | 155.17% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.3266 |
| Last Split Factor | 1:23467182 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | February 28, 2026 |
| Most Recent Quarter (mrq) | February 28, 2026 |
| Next Fiscal Year End | February 28, 2027 |
Profitability
| Profit Margin | 11.75% |
| Operating Margin (ttm) | 10.94% |
| Gross Margin | 58.96% |
| EBITDA Margin | 15.31% |
Management Effectiveness
| Return on Assets (ttm) | 3.15% |
| Return on Equity (ttm) | 6.81% |
Income Statement
| Revenue (ttm) | 163.02B USD |
| Revenue Per Share (ttm) | 2284.98 USD |
| Quarterly Revenue Growth (yoy) | 8.40% |
| Gross Profit (ttm) | 96.12B USD |
| EBITDA | 24.97B USD |
| Net Income Avi to Common (ttm) | 19.16B USD |
| Diluted EPS (ttm) | 1.73 |
| Quarterly Earnings Growth (yoy) | -10.19% |
Balance Sheet
| Total Cash (mrq) | 118.64B USD |
| Total Cash Per Share (mrq) | 1685.16 USD |
| Total Debt (mrq) | 2.38B USD |
| Total Debt/Equity (mrq) | 0.81 USD |
| Current Ratio (mrq) | 4.084 |
| Book Value Per Share (mrq) | 26.420645 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 17.48B USD |
| Levered Free Cash Flow (ttm) | 1B USD |
Profile of Hisamitsu Pharmaceutical
| Country | United States |
| State | N/A |
| City | Tosu |
| Address | Tashirodaikan-machi 408 |
| ZIP | 841-0017 |
| Phone | 81 3 5293 1720 |
| Website | https://www.global.hisamitsu |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. As of February 19, 2026, Hisamitsu Pharmaceutical Co., Inc. operates as a subsidiary of Taiyo Kosan Co., Ltd.
Q&A For Hisamitsu Pharmaceutical Stock
What is a current HTSUF stock price?
Hisamitsu Pharmaceutical HTSUF stock price today per share is 29 USD.
How to purchase Hisamitsu Pharmaceutical stock?
You can buy HTSUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hisamitsu Pharmaceutical?
The stock symbol or ticker of Hisamitsu Pharmaceutical is HTSUF.
Which industry does the Hisamitsu Pharmaceutical company belong to?
The Hisamitsu Pharmaceutical industry is Drug Manufacturers - Specialty & Generic.
How many shares does Hisamitsu Pharmaceutical have in circulation?
The max supply of Hisamitsu Pharmaceutical shares is 70.4M.
What is Hisamitsu Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Hisamitsu Pharmaceutical PE Ratio is 16.76300600 now.
What was Hisamitsu Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Hisamitsu Pharmaceutical EPS is 1.73 USD over the trailing 12 months.
Which sector does the Hisamitsu Pharmaceutical company belong to?
The Hisamitsu Pharmaceutical sector is Healthcare.